Image Viewer

Gene-editing pioneer advocates for significant investment in Crispr technology to make medical therapies accessible globally. Challenges in connecting patients with rare diseases to CRISPR treatments persist despite advancements in science and technology. Lab-developed tests could play a crucial role in bridging this gap.